In its 9th year of publication Human Vaccines and Immunotherapeutics (HV&I) has become well-established in the vaccine community as an important forum for academics, companies, governmental and non-governmental organizations in this field. Our journal contains a mix of high-quality original research and solicited content including timely reviews, commentaries, news, portraits, and much more. Its unique and exclusive focus on vaccines and immunotherapeutics for human use coupled with the rapid and efficient editorial processing of submitted papers has allowed HV&I to continuously increase its content and progressively improve its standing relative to other journals in the field.
Obviously, the successful development of HV&I would not have been possible without the many scientists and editors who have served as peer reviewers for HV&I. We want to take this opportunity to thank all our reviewers for their time and commitment. All peer reviewers of 2012 are listed below.
In particular, we are very pleased to recognize Dr John Schiller (National Cancer Institute, NIH, Bethesda, MD, USA) as Top Reviewer 2012 for Human Vaccines and Immunotherapeutics. On behalf of Landes Bioscience, we want to thank him for his commitment.
Previous Awardees were Drs Brian Greenwood (London School of Hygiene and Tropical Medicine, UK), Brian Ward (McGill University, Montreal, Canada), James Tartaglia (Sanofi-Pasteur, Toronto, Canada), Joel Bozue (USAMRIID Bacteriology, Fort Detrick, MD, USA), Mark Kane (Consultant, Mercer Island, Seattle, WA, USA), and Arístides Aguilar Betancourt (Centre for Genetic Engineering and Biotechnology, Biomedical Research Branch, Vaccines Division, Havana, Cuba).
Syed Abbas
Public Health Foundation of India
Jeff Alexander
Paxvax
Ananda Amarasinghe
Ministry of Health
Robert Amato
University of Texas Medical School
Christopher S. Ambrose
MedImmune, LLC
Robin F. Anders
La Trobe University
Annaliesa S. Anderson
Pfizer
Sébastien Anguille
Antwerp University Hospital
Silke Appel
University of Bergen
Adriano Arguedas
Instituto de Atenciótrica
Toni Ashton
University of Auckland
Sita Awasthi
University of Pennsylvania
Martin Bachmann
University of Zurich
Hong Bai
University of Manitoba
Albert Barskey
CDCP
Linda Baum
Rush University Medical
David N. Baxter
Manchester University Medical School
Robert Belshe
St Louis Univ Medical Center
Arístides Aguilar Betancourt
Center for Genetic Engineering and Biotechnology
Prakash K. Bhuyan
Pfizer
Joke Bilcke
University of Antwerp
Robert Binder
University of Pittsburgh
Jana Blazkova
National Institute of Allergy and Infectious Diseases
Beatrice Blondel
INSERM
Jean Boyer
University of Pennsylvania School of Medicine
Joel Bozue
USAMRIID Bacteriology
Michael Bröker
Novartis Vaccines and Diagnostics GmbH
Kristina A Bryant
University of Louisville
Giuseppina Campisi
University of Palermo
Chuan Hai Cao
University of South Florida
Pere-Joan Cardona
Unitat de Tuberculosi Experimental
Javier Carrero
Washington University School of Medicine
Robert Cartee
Matrivax Corp
Sofia Casares
Walter Reed Army Institute of Research
Antonio Cassone
Parasitic and Immuno-mediated Diseases Istituto Superiore di Sanità
Flora Castellino
Novartis
Robert T Chen
CDCP
Carlos Chiatti
Italian National Institute of Health and Science on Aging
Gabby Chodick
Maccabi Healthcare Services
Mara Cirone
La Sapienza University
Liana Clark
Merck
Sarah J. Clark
University of Michigan
Rhea Coler
Infectious Disease Research Institute
Richard Connolly
University of South Florida
Tim Cooke
NovaDigm Therapeutics Inc.
Wayne Crill
Centers for Disease Control and Prevention
Andre Pires da Cunha
Brigham and Women’s Hospital
Margaret Danchin
University of Melbourne
Sanjoy Kumar Datta
GlaxoSmithKline Biologicals
Adil Daud
University of California at San Francisco
Robert S. Daum
University of Chicago
Sunil A. David
University of Kansas
Anne S. De Groot
Epivax, Inc. and University of Rhode Island
Tanja De Gruijl
Free University of Amsterdam
J.C. de Jong
Erasmus Medical Center
Gennaro De Libero
University Hospital Basel
Chiara de Waure
Catholic University of the Sacred Heart
Shayesta Dhalla
University of British Columbia
Javier Diez Domingo
Instituto Valenciano de Vacunas, Spain
Andrew Dudley
University of North Carolina
Lesley Dupuy
United States Army Medical Research Institute of Infectious Diseases
Tonyia Eaves-Pyles
University of Texas Medical Branch
Robert Edelman
University of Maryland School of Medicine
Mark H. Einstein
Albert Einstein College of Medicine
Jose Esparza
Gates Foundation
Susanna Esposito
University of Milan
Jean-Louis Excler
International AIDS Vaccine Initiative
Neil Fairweather
Imperial College London
Ewout Fanoy
National Institute for Public Health and the Environment
M.M.A. Faridi
University College of Medical Sciences
Ian Feavers
National Institute for Biology Standards and Controls
Barbara Felber
Frederick National Laboratory for Cancer Research
Zongdi Feng
University of North Carolina—Chapel Hill
Guido Ferrari
Duke University Medical Center
Matthew Ferrari
Pennsylvania State University
Bernadette Ferraro
University of Pennsylvania
Jamie Findlow
Health Protection Agency
Marc Fischer
Centers for Disease Control and Prevention
André Frenzel
Technische Universitat Braunschweig
Chuanxi Fu
Guangzhou Center for Disease Control and Prevention
Tong Ming Fu
Merck Research Laboratories
Guro Gafvelin
Karolinska Institutet
James E. Galen
University of Maryland School of Medicine
Lisa Ganley-Leal
Boston University School of Medicine
Natalie Garcon
GlaxoSmith Kline Biologicals
Norberto Giglio
Hospital de Niños Ricardo Gutierrez
Vladimir Gilca
Institut National de Sante Publique du Quebec
Melissa Gilkey
University of North Carolina
Marc Girard
French National Academy of Medicine
Paul Goldwater
Women’s and Children’s Hospital
Gisela Gonzalez
Center of Molecular Immunology
Shelley Gorman
University of Western Australia
Andrew Gorringe
Health Protection Agency
Yasuyuki Goto
University of Tokyo
Guido Grandi
Novartis Vaccines and Diagnostics Srl
James Gray
Norfolk and Norwich University Hospital
Bruno Guy
Sanofi Pasteur
Carlos Guzman
Helmholtz Centre for Infection Research
James Hadler
Yale University School of Public Health
James Hadler
Yale University School of Public Health
Mawieh Hamad
University of Sharjah
Susan Hariri
CDCP
Rafael Harpaz
Centers for Disease Control and Prevention
Diane Harper
University of Missouri —Kansas City
Jukka Hartikka
Vical Inc.
Mary S. Hayney
University of Wisconsin
Franz Heinz
Medical University of Vienna
Maren Henneken
Landspitali
Sander Herfst
Erasmus Medical Center
Ann Hessell
Oregon Health and Science University
Florence Hofman
University of Southern California
Harry F. Hull
HF Hull and Associates, LLC
Peter Hunt
University of California—San Francisco
Natalie Hutnick
University of Pennsylvania
Giancarlo Icardi
University of Genoa
Toshiaki Ihara
Mie National Hospital
Hiroaki Ikeda
Mie University Graduate School of Medicine
Geneviève Inchauspe
Transgene SA
Ken J. Ishii
Osaka University
Glenn Ishioka
Paxvax
John Iskander
CDCP
Yasushi Itoh
Shiga University of Medical Science
Kathryn Jacobsen
George Mason University
Kathrin U Jansen
Pfizer
Bernd Jilma
Medical University of Vienna
Rodrigo Jimenez-Garcia
Universidad Rey Juan Carlos
Huali Jin
Ceva Biomune
Gareth Jones
Animal Health and Veterinary Laboratories Agency
LaToya Jones-Braun
University of Colorado —Denver
Linda M. Kaljee
Wayne State University
Robert Kaminski
Walter Reed Army Institute of Research
June Kan-Mitchell
University of Texas—El Paso
Lana Kandalaft
University of Pennsylvania School of Medicine
Mark A. Kane
Consultant
Stefan Kappe
Seattle Biomedical Research Institute
Tom Karagiannis
Baker IDI Heart and Diabetes Institute
Mira Katz
Ohio State University
Paul B. Keiser
Walter Reed National Military Medical Center
Stephen Kent
The University of Melbourne
Peter Khoury
Baxter Vaccines
Margaret Kline
National Institute of Standards and Technology
Dennis Klinman
National Cancer Institute
Shelly Krebs
Walter Reed Army Institute for Research
Joost H.C.M. Kreijtz
Erasmusm Medical Center
John Kriesel
University of Utah
Alex Kudrin
Medicines and Healthcare products Regulatory Agency
Prasad Kulkami
Serum Institute of India
Max Kullberg
University of Colorado Denver
Michael Kurilla
National Institute of Allergy and Infectious Diseases
Diego Laderach
Universidad de Buenos Aires
Sanjay Lalwani
Bharti Vidyapeeth University Medical College and Hospital
Roger Le Grand
CEA
Hyunju Lee
Seoul National University Bundang Hospital
José Paulo Gagliardi Leite
Oswaldo Cruz Institute
Hagai Levine
The Hebrew University of Jerusalem—Hadassah Medical Organization
Sharon Lewin
Alfred Hospital
Jonathan Z Li
Brigham and Women’s Hospital
Chiara Lico
ENEA C.R. Casaccia
Tzou-Yien Lin
Chang Gung Children’s Hospital, Chang Gung Memorial Hospital, Chang Gung University
Alexandre Linhares
Brazilian Ministry of Health
Adriana Lopez
CDCP
Anna Lena Lopez
International Vaccine Institute
Jeanne Loughlin
Optimum Insight
Shan Lu
University of Massachusetts Medical School
Anna Lugnér
National Institute for Public Health and the Environment
Laurence Lum
Wayne State University
Nils Lycke
University of Gotebog
Shampur Narayan Madhusudana
National Institute of Mental health and Neurosciences (NIMHANS)
Aba Mahamat
Cayenne General Hospital
Claudius Malerczyk
Novartis Vaccines
Elpis Mantadakis
Democritus University of Thrace Medical School and University of Greece
Lamberto Manzoli
University of Chieti
Federico Marchetti
GlaxoSmithKline S.p.A
Mona Marin
CDC, Immunization Safety Office
Domenico Martinelli
University of Foggia
Paul Matejschuk
National Institute for Biological Standards and Control
Scott McDonald
RIVM
David McMurray
Texas A&M Health Science Center
Steven Mizel
Wake Forest University School of Medicine
Gregory Moe
Children’s Hospital and Research Center
Leonard Moise
Epivax, Inc. and University of Rhode Island
Matthew Morrow
Inovio
Ayesha Murshid
Harvard Medical School
Osamu Nakagomi
Nagasaki University
Edmund Anthony Nelson
The Chinese University of Hong Kong
Mark Newman
Consultant
Glen Nowak
CDCP
Susan Nyland
Penn State University
Miguel O’Ryan
University of Chile
Olga Ochoa-Gondar
Institut Català de la Salut
Suzanne Ohmit
University of Michigan
Douglas J Opel
University of Washington School of Medicine
Giulia Orsini
University of Pisa
Christian Ottensmeier
University of Southhampton
Laura Pabst
CDCP
David Pace
University of Oxford
Sushil Kumar Pathak
Karolinska University Hospital
Yvonne Patterson
Universityof Pennsylvania
Sudesh Pawaria
University of Pittsburgh
Mark Pearson
James Cook University
Haiyan Peng
Ohio State University
Tony Pernthaner
AgResearch Limited
Matthieu Perreau
University of Lausanne
Nikolai Petrovsky
Flinders Medical Centre
Michael E. Pichichero
Rochester General Hospital Research Institute
Yong Poovorawan
Chulalongkorn University
Christine Posavad
University of Washington
Pietro Presicce
Cincinnati Children’s Hospital Medical Center
Firdausi Qadri
International Center for Diarrheal Disease Research
Naveen Rajasagi
University of Tennessee
Paul L. Reiter
The Ohio State University
Morgan A. Reuter
University of Pennsylvania, Perelman School of Medicine
Guus F. Rimmelzwaan
Erasmus Medical Center
Harriet L. Robinson
GeoVax, Inc.
Gustavo Romero
Universidade de Brasília
Antonio Rosato
University of Padua
Catherine Sadzot-Delvaux
University of Liege
Akihiko Saitoh
Niigata Graduate School of Medical and Dental Sciences
Sandra Aparecida dos Santos
University of São Paulo—School of Medicine of Ribeirão Preto
John Schiller
National Cancer Institute
Jacob Joseph Schlesinger
University of Rochester
Achim Schneeberger
AFFIRIS AG
Tino F. Schwarz
Central Laboratory and Vaccination Centre, Stiftung Juliusspital,
Tino F. Schwarz
Central Laboratory and Vaccination Centre, Stiftung Juliusspital,
Thomas Scriba
University of Cape Town
Sergie Seregin
Michigan State University
A. Sharma
Uniformed Services University of the Health Sciences
Hitt Jyoti Sharma
Serum Institute of India Ltd
Jufang Shi
Cancer Council New South Wales
Tom Shimabukuro
Centers for Disease Control and Prevention (CDC)
Freddy Sitas
Cancer Council of New South Wales
Hiie Soeorg
University of Tartu
Jo Southern
Health Protection Agency
Jeffrey Stoddard
Novartis Vaccines and Diagnostics
Klaus Stohr
Novartis Vaccines
Andrea Streng
Julius-Maximilians-University of Würzburg
Raymond A. Strikas
Center for Disease Control and Prevention
Shigeru Suga
Mie National Hospital
Silvio Tafuri
University of Bari Aldo Moro
Michael Tal
NasVax
Tina Tan
Northwestern University
James Tartaglia
Sanofi Pasteur
Dirk Teuwen
UCB Pharma
R.E. Thomas
University of Calgary
Wayne Robert Thomas
University of Western Australia
Kenneth E. Ugen
University of South Florida
Jeffrey B. Ulmer
Novartis Vaccines
Mark van der Linden
Universität-sklinikum Aachen
Nicoline A.T. van der Maas
National Institute for Public Health and the Environment
Vitaly Vasilevko
University of California—Irvine
Ashley Vaughan
Seattle Biomedical Research Institute
Alejandro Villagra
Moffitt Cancer Center and Research Institute
Simonetta Viviani
Meningitis Vaccine Project
Chelsea Voytek
University of Pennsylvania
Jo Waller
UCL
Bin Wang
China Agricultural University
Duncheng Wang
University of British Columbia
Duncheng Wang
University of British Columbia
Brian J. Ward
McGill Univ, Div of Infectious Diseaes
Michael Watson
Sanofi Pasteur
Jon Weidanz
Texas Tech University Health Sciences Center
David B. Weiner
Univ Pennsylvania School of Medicine
Bruce G. Weniger
Chiang Mai University
Ranjan Wijesinghe
College of Community Physicians of Sri Lanka
Karl Wooldridge
University of Nottingham
Dorothy K.L. Xing
NIBSC
Akihiko Yamamoto
National Institute of Infectious Diseases
Catherine Yen
Centers for Disease Control and Prevention
Dace Zavadska
Riga Stradins University
Ziad Zeinoun
GlaxoSmithKline Biologicals
Qinjian Zhao
Xiamen University
Tongqing Zhou
National Institute of Allergy and Infectious Disease
Gui-hua Zhuang
Xi’an Jiaotong University
Footnotes
Previously published online: www.landesbioscience.com/journals/vaccines/article/23666